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| INTRODUCTION
Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is the most common form of hereditary small vessel disease and is the most common genetic cause of stroke and vascular dementia in adults. 1, 2 The clinical presentation of CADASIL is characterized by migraine with aura, transient neurological symptoms, mood disturbances and cognitive impairment. [3] [4] [5] [6] [7] Pathological characteristics evident in the brain of patients with CADASIL include deposits of granular osmiophilic material (GOM) in close vicinity to the basement membrane that surrounds vascular smooth muscle cells (VSMCs) of parenchymal arterioles, 8, 9 and degeneration of VSMCs 10, 11 in small and medium-sized arteries. 12, 13 Subsequent to VSMC degeneration, fibrotic thickening of the vessel walls and narrowing of the lumina of small penetrating arterioles occur predominantly in cerebral white matter. 14 The resulting blood flow restriction leads to characteristic ischaemic changes, white matter loss and lacunar infarcts. 14 White matter changes observed via magnetic resonance imaging (MRI) are a characteristic feature of CADASIL that have been utilized as an indication of the disease. 15, 16 CADASIL is caused by mutations in the NOTCH3 gene. NOTCH3
is a type I transmembrane receptor belonging to the Notch signalling family, one of a group of "elite" intracellular signalling pathways. 17, 18 Currently, more than 230 different CADASIL-causing mutations in the NOTCH3 gene have been detected, 19 which are either missense mutations or small in-frame deletions in the epidermal growth factor repeats of NOTCH3. These mutations affect the number of cysteine residues, leading to an unpaired cysteine residue. [20] [21] [22] [23] [24] In CADASIL, pathological observations have shown abnormality in numerous cells within neurovascular units, including VSMCs and endothelial cells (ECs). 25, 26 Therefore, alterations to each cell type within the neurovascular unit can affect the vulnerability of blood vessels in CADASIL. 25 In CADASIL, the outer layer of the vessels consisting of VSMCs becomes thinner, while the endothelial layer that is surrounded by the VSMCs becomes swollen and loses its integrity due to gap junction loss. 25, 26 This leads to microbleeds, occlusion and/or thrombosis. 27, 28 It has been proposed that the degeneration of the smooth muscle layer in arteries/arterioles of patients with CADASIL is the result of increased VSMC death. 11, 29 There is meagre evidence that the thinning of the tunica media is due to VSMC loss or degeneration by cell death. In a recent study, we suggested that the reduced number of cells is rather due to impaired VSMC proliferation. 29 We showed that VSMCs from CADASIL patients with the R133C mutation in NOTCH3 have a lower proliferation rate than control VSMCs. 29 Transforming growth factor-b (TGFb) is a cytokine that has multicellular function in the cells and has a great involvement in the fibrosis of several diseases. The role of TGFb in cell proliferation is well-established. 30 Dysregulation of the TGFb signalling pathway has been proposed in CADASIL by showing increased levels of the TGFb pro-domain. 31 Furthermore, latent 
| MATERIAL AN D METHODS

| Cell lines and genotyping
Patient-derived VSMC cell lines: umbilical cord (Umb)-and placental (Pla) VSMCs were established from blood vessels of genetically verified patients with CADASIL and control subjects as previously described. 34, 35 The genotyping of the cerebral arterial (Cer) VSMC cell line 35 was also verified ( Figure S1A ).
| Cell culture
Patient-derived VSMC cell lines: Umb-, 29 Pla-and CerVSMC and human foreskin fibroblasts were cultured as described previously. 35 Equal numbers of CFSE-labelled cells were incubated for either 3 or 7 days. Unlabelled cells were used as negative controls. Flow cytometry was performed using a FACSCalibur ™ Cytometry, and data were analysed using the CellQuest software (BD Biosciences). The proliferation rate of VSMCs was also investigated using immunofluorescent staining of the proliferation-associated Ki67 protein as previously described. 29 The quantification of Ki67 positive cells was based on the evaluation of at least 500 cells.
2.4 | Exposure of fibroblasts and VSMC to CADASIL PlaVSMC-conditioned medium
Human fibroblasts and UASMC were exposed to media that CADA-SIL PlaVSMC cells were grown in conditioned medium for 24 hour, and 3 and 7 days. The PlaVSMC-conditioned medium was applied either undiluted or diluted 1:1 with complete medium. The proliferation rate of VSMCs was investigated using immunofluorescence staining of the proliferation-associated Ki67 protein as described previously. 29 The ratio of Ki67 positive cells was based on the evaluation of at least 500 cells. Experiments were performed in triplicate.
| Quantitative real-time polymerase chain reaction (qRT-PCR) of genes related to cell proliferation
RNA was isolated from Pla-and CerVSMC using the RNeasy Mini 
| Co-culture of VSMCs and ECs in transwell system
To examine the effect of TGFb produced by VSMC on EC proliferation rates, Pla-and CerVSMC were co-cultured with ECs in a noncontacting co-culture transwell system (Pore size 0.4 lm, Life Technologies). Endothelial cells were plated at 5 9 10 4 cells/mL in 6-or 24-well plates. Pla-and CerVSMCs were seeded at 5 9 10 4 cells/ mL onto the membrane of transwell cell culture inserts and allowed to grow overnight. After 24 hour, the transwell insert membrane containing the VSMCs was placed into plates containing ECs. Vascular smooth muscle cells were treated with a TGFb-neutralizing antibody (12 lg/mL). (Table S1 , data not shown, respectively).
| Statistical analysis
We found an increase expression of all TGFb isoform families 
| DISCUSSION
One of the major pathological findings of CADASIL is degeneration of small arterioles due to the loss of myocyte cell coverage. 11 Previously, we have demonstrated that VSMCs derived from patient with CADASIL have a lower proliferation. 29 In this study, we have revealed that the lower proliferation rate of these cells affects neighbouring ECs. In addition, we demonstrated that this inhibition of proliferation occurs in a paracrine fashion by inhibiting cell to cell contact using a transwell system. This paracrine mechanism seems to be due to a compound that is secreted by VSMC, and one cytokine that could potentially explain this phenomenon in CADASIL is TGFb. By blocking this cytokine using an anti-TGFb antibody, we were able to restore CADASIL VSMCs and ECs co-cultured with CADASIL VSMCs to a proliferation rate that resembles the proliferation rate of ECs co-cultured with control VSMCs.
Transforming growth factor-b has been shown to be involved in differentiation/proliferation of VSMCs. 30, 37 Dysregulation of the TGFb signalling pathway has been proposed to play a role in CADA-SIL as observed by an increased levels of the TGFb. 31 The TGFb family implication in fibrosis is most interesting as fibrotic thickening of small vessels in CADASIL is widely reported. 38 It has been suggested that the damage of VSMCs in CADASIL induces secondary fibrosis with consequent thickening of the walls and narrowing of the lumen of cerebral arteries. 19 In this study, we found elevated expression level of TGFb isoforms (TGFb1, TGFb2 and TGFb3) in Plaand CerVSMCs, where the increased level of TGFb3 was more obvious as compared to the TGFb1 or TGFb2. TGFb isoforms are expressed in the central nervous system and among them, TGFb1 has been widely considered as an injury-related cytokine which is a F I G U R E 2 Proliferation rate of foreskin fibroblasts cultured in Cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) PlaVSMC-conditioned medium. A, Human fibroblasts were incubated with PlaVSMC-conditioned medium for 1, 3 and 7 days, stained with Ki67 antibody and analysed by confocal microscopy. B, Umbilical artery smooth muscle cells (UASMCs) were also incubated with CADASIL and control PlaVSMCs -conditioned medium. C, D, qRT-PCR analysis of TGFb3 gene in Pla-and CerVSMCs. The expression of TGFb3 gene was normalized to the endogenous control gene; HPRT1, and the RQ (Relative Quantitation) was calculated using control VSMC normalized to 1. **P < .01, ***P < .001. The results are representative of three independent biological replicates (n = 3). One-way ANOVA followed by Bonferroni's post hoc test was used for statistical analysis crucial regulator of nervous system physiology and its vasculature. TGFb3. [40] [41] [42] TGFb3 has also been detected in uninjured epithelium.
However, distinct effects of vascular-derived TGFb3 have not been elucidated in small vessel diseases and CADASIL. In the current study, we found an up-regulation of TGFb3 gene expression in CADASIL VSMCs. Other TGFb-isoforms genes were also expressed higher in CADASIL VSMCs compared to control VSMCs. Variability in expression of the TGFb3 gene could result in enhanced myofibroblast activity, proliferation and induction of ECM synthesis. 43, 44 A previous study has identified elevated genes related to ECM proteins and collagens in CADASIL. 45 There is a possibility that the observed increased secretion of TGFb-isoforms, in particular TGFb3 in our study, could be involved in induction of ECM protein synthesis and fibrosis formation that disrupts the normal architecture of vasculature in CADASIL. Whether fibrosis is a general response to degeneration of VSMCs or because of the activation of TGFb-specific fibrotic pathways is still to be examined.
Degenerative changes in capillary vessels are also involving ECs in CADASIL and showing endothelial abnormalities which suggests a secondary character of endothelium damage in CADASIL. 46 EC function in blood vessels is regulated by coordination of vascular VEGF, Notch and TGFb. 47 Studies have shown that signalling of TGFb/ ALK1-Smad1/5 stimulates EC migration and proliferation. 48 Inhibition of endoglin in ECs, which is a part of the TGFb receptor complex, potentiates TGFb/ALK1 signalling, 49, 50 resulting in reduced proliferation. 51, 52 TGFb binds to its specific receptors including TGFbR3. TGFbR3 is one of the proteins that have a more indirect role in TGFb signal transduction. 33 The down-regulation of TGFbR3 on EC potentiates the inhibitory effect of TGFb on EC migration and growth. 50 We investigated whether TGFb receptor expression may have an impact on EC proliferation in ECs co-cultured with CADASIL VSMCs. Our qRT-PCR data showed down-regulation of TGFbR3 in ECs co-cultured with CADASIL VSMCs (Table S2 , Figure S5 ), while specification. The TGFb signalling pathway is known to be involved in modulation of cyclin genes. 55 We have also observed down-regulation of cyclins gene expression in CADASIL VSMCs, suggesting that TGFb signalling pathway may exert its effect on cyclin genes.
In CADASIL, the cells in the vasculature can be exposed to complex changes, such as aggregated NOTCH3, and GOM. In this study, we have implicated TGFb and TGFb receptors as additional players in CADASIL disease. Therefore, more detailed studies are needed to elucidate the interplay of TGFb signalling in the vasculature in CADASIL. In summary, our data provide evidence for direct involvement of TGFb in proliferation of VSMCs and ECs. We believe that our findings provide a better understanding of the pathogenesis of CADASIL disease.
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